All Stories

  1. Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
  2. In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
  3. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
  4. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations
  5. The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
  6. The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias
  7. Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
  8. TP53 mutations and Azacitidine treatment: To be or not to be related?
  9. Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome
  10. Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector
  11. BCR/ABL1-positive acute lymphoblastic leukemia relapsing asBCR/ABL1-negative acute lymphoblastic leukemia
  12. Cytogenetics in myelodysplastic syndromes: Old methods, new clues
  13. Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan
  14. Clonal evolution including 14q32/IGHtranslocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients
  15. Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma
  16. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB–NDE1 fusion
  17. Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia
  18. Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report
  19. Biological and Clinical Implications of Recruitment of Stem Cells into Angiogenesis
  20. The role of rHuEpo in low-risk myelodysplastic syndrome patients
  21. Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological Findings
  22. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical–biological findings*
  23. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics
  24. Differentiation of follicular dendritic sarcoma cells into functional myeloid‐dendritic cell‐like elements
  25. rHuEpo administration in patients with low‐risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May–Grunwald–Giemsa‐stained bone marrow samples
  26. Dendritic cells in acute promyelocytic leukaemia
  27. The Monocytic Component in Myelodysplastic Syndromes
  28. Secondary Chromosome Changes in Mantle Cell Lymphoma: Cytogenetic and Fluorescence in situ Hybridization Studies
  29. ‘Isolated’ Thrombocytopenia by Splenic Sequestration in Hemodialyzed Patients
  30. Phenotypic and functional characteristics of monocyte‐derived dendritic cells from patients with myelodysplastic syndromes
  31. Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings
  32. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients
  33. An unusual case of untreated chronic lymphocytic leukemia patient presenting with Rhodococcus equi bacteriemia
  34. An unusual case of untreated chronic lymphocytic leukemia patient presenting withRhodococcus equi bacteriemia
  35. CD34 Quantitative Flow Cytometry Study of the Blastic Population in Acute Leukemias
  36. Photomultiplier voltage setting: Possible important source of variability in molecular equivalents of soluble fluorochrome (MESF) calculation?
  37. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome
  38. Atypical chronic lymphocytic leukaemia witht(ll;14)(ql3;q32): karyotype evolution and prolymphocytic transformation
  39. CD34+/CD33+ Blast Cells: Correlation with FAB Subtypes
  40. CD34+ Leukemic Cells Assessed by Different CD:34 Monoclonal Antibodies
  41. Prognostic Value of Immunophenotypic Characteristics of Blast Cells in Acute Myeloid Leukemia
  42. Neutrophils from Patients with Myelodysplastic Syndromes: Relationship between Impairment of Granular Contents, Complement Receptors, Functional Activities and Disease Status
  43. Chromosome aberrations in CD34-positive acute myeloid leukemia